Introduction
Methods
Study setting
Targeted problems
Study phases and their components
Phase 1
Capturing performance adjustments in everyday clinical work
Identifying a mechanism for interruptions and interventional points
Developing an intervention scheme in a synthetic manner
Phase 2
Implementing the intervention in daily operations
Assessing the outcome of changed practices
Statistical Analysis
Results
Phase 1
Performance adjustments of pharmacists and nurses
Inpatient wards | Outpatient departments | Others | Total | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Oral or topical medicines | Injectables | |||||||||
Reasons for inquiries | N | (%) | N | (%) | N | (%) | N | (%) | N | (%) |
Requests for earlier receipts at the service counter | 121 | (57.9%) | 155 | (50.5%) | 12 | (7.6%) | 1 | (4.2%) | 289 | (41.5%) |
Checking the dispensing and delivery status | 53 | (25.4%) | 45 | (14.7%) | 3 | (1.9%) | 0 | (0%) | 101 | (14.5%) |
Requests for earlier-than-scheduled deliveries with machine transportation | 19 | (9.1%) | 90 | (29.3%) | 134 | (85.4%) | 1 | (4.2%) | 244 | (35.0%) |
Others | 16 | (7.7%) | 17 | (5.5%) | 8 | (5.1%) | 22 | (91.6%) | 63 | (9.0%) |
Total phone calls for five consecutive days | 209 | (100%) | 307 | (100%) | 157 | (100%) | 24 | (100%) | 697 | (100%) |
Average phone calls per day | 42 | 61 | 31 | 5 | 139 |
Mechanism for the emergence of interruptions
Determining the interventional components
Phase 2
Implementation of the interventional measures
Effect of the implemented measures
Before | After | |||
---|---|---|---|---|
Sources of interruptions | Median (IQR) | Median (IQR) | P Value | FDR-adjusted P Value |
Telephone inquiries | ||||
Total | 43 (38–46) | 18 (18–19) | .032 | |
Requests for earlier receipts at the service counter | 26 (22–28) | 9 (9–13) | .032 | |
Checking the dispensing and delivery status | 10 (9–12) | 1 (1–1) | .008a | |
Requests for earlier-than-scheduled deliveries with machine transportation | 4 (3–4) | 1 (1–3) | .151 | |
Others | 3 (3–4) | 4 (4–6) | .548 | |
Counter services | ||||
Total | 55 (51–56) | 15 (15–15) | .008 | |
Topical and oral medicines | 19 (18–22) | 2 (2–3) | .008b | |
Injectable medicines | 14 (12–14) | 1 (1–2) | .008b | |
Others | 17 (15–19) | 12 (12–13) | .095 |